Recent studies showing that gastric bypass surgery extends the lives of obese patients is forcing surgeons to make tough decisions about who should go under the knife and who shouldn’t.
Read More »Research Finds Three-Quarters of Youths With Diabetes Insufficient In Vitamin D
Study urges supplementation of vitamin D to protect bones later in life for those children found to be deficient in vitamin D (75%).
Read More »Diabetes Linked To Risk Of Lymphoma
More cases of blood cancers classified as non-Hodgkin’s lymphoma, or NHL, seem to occur among people with diabetes than those without, researchers report.
Read More »Sleep Apnea Treatment Reduces Nighttime Blood Sugar
Patients with type 2 diabetes and obstructive sleep apnea who used continuous positive airway pressure (CPAP) saw improved glycemic control during the night.
Read More »Psoriasis, Metabolic Syndrome Linked to High Leptin Levels
Psoriasis and metabolic syndrome both are associated with high serum levels of leptin, according to a new report. “Body weight loss could potentially become part of the general treatment of psoriasis, especially in patients with obesity.”
Read More »Next DPP-4 inhibitor (Alogliptin) Found Safe and Effective in Poorly Controlled Type 2’s
Therapy with alogliptin alone is significantly reduced glycosylated hemoglobin A1c levels in patients with type 2 diabetes and inadequate glycemic control, according to a double-blind, placebo-controlled, multicenter trial reported this month.
Read More »Atorvastatin, Fenofibrate Fixed Combo Is Effective For Mixed Dyslipidemia
A once-daily, fixed-dose tablet combining atorvastatin and a novel micronized formulation of fenofibrate outperformed either drug alone in a phase II clinical trial in patients with mixed dyslipidemia.
Read More »Insulin Levels Predict Survival Odds in Colon Cancer Patients
Blood levels of two insulin-related proteins are able to predict which patients with colon cancer are most likely to die of their disease by 87%, new research suggests.
Read More »Arena Pharmaceuticals Announces First In Class Treatment for Type 2 Diabetes Begins Phase 1 Trial
Phase 1 clinical trial of APD597, a novel first in class oral drug candidate that targets the glucose-dependent insulinotropic receptor (GDIR) for the treatment of type 2 diabetes will begin shortly. The GDIR has the potential to stimulate insulin release in response to increases in blood glucose. Ortho-McNeil-Janssen Pharmaceuticals will be …
Read More »Diabetic Binge Eaters Can Still Lose Weight
The success of weight-loss in overweight and obese individuals with type 2 diabetes is not affected by a history of binge eating, according to a report in the Archives of General Psychiatry.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.